InnovaHealth Partners

InnovaHealth Partners is a private equity firm based in New York, founded in 2016, that focuses on investments in the medical technology sector. The firm specializes in buyout and growth investments, primarily targeting late-stage companies that develop medical devices and disruptive technologies. InnovaHealth Partners seeks to acquire controlling positions as a lead investor in its portfolio companies, which are typically located in the United States, Europe, and Israel. The firm aims to identify and support innovative organizations that can advance healthcare through technology and improved medical solutions.

Toby Cosgrove

Senior Partner

Ross Julian

Associate Director

11 past transactions

Route 92

Series F in 2024
Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke care.

Materna Medical

Venture Round in 2024
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce maternal childbirth-related injuries during vaginal delivery. Established in 2010, the company addresses significant unmet needs in women's pelvic health, positioning itself within a $6 billion market. Materna Medical aims to transform the standard of care in obstetrics and gynecology by leveraging advanced technologies and a diverse team of engineers, scientists, and commercial leaders. The company’s mission is to empower women to safeguard their pelvic health through its novel medical devices.

Route 92

Series F in 2023
Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke care.

Switchboard Health

Seed Round in 2023
Switchboard Health is a healthcare technology company founded in 2023 and headquartered in Boise, Idaho. It provides a specialty care network platform designed to enhance access to integrated and comprehensive healthcare services. The company focuses on leveraging virtual care solutions to assist payers, health systems, employers, and at-risk providers in managing patient care at scale. Switchboard Health's platform simplifies specialty referrals and connects individuals with appropriate providers, while also offering navigator support, integrated data, and outcomes measurement. This approach aims to improve the patient care journey, facilitate access to primary care and digital health services, and enhance coordination outcomes for employers and payers by reducing overall costs.

Radiaction

Series C in 2023
Radiaction Medical, Ltd. is an innovative company based in Tel Aviv, Israel, that specializes in radiation protection solutions for interventional medical teams, particularly in high-exposure fields like interventional cardiology and electrophysiology. The company has developed Radiaction, a plug-and-play system that integrates with existing C-arm fluoroscopy systems to dynamically block over 90% of scatter radiation at its source, providing comprehensive head-to-toe protection for all personnel in the operating room. This approach marks a significant advancement over traditional protective measures such as lead aprons and shields. Radiaction has received both CE Marking and FDA clearance, facilitating its marketing in North America. Founded by Amir Belson, MD, and supported by lead investor InnovaHealth Partners, Radiaction Medical aims to address real-world challenges in radiation safety through engineering excellence and innovation.

Monteris Medical

Venture Round in 2022
Monteris Medical, Inc. is a medical device company specializing in the development and marketing of innovative technologies for the treatment of brain diseases. Founded in 1999 and based in Plymouth, Minnesota, with additional offices in Minneapolis and Winnipeg, the company focuses on minimally-invasive, MRI-guided, and robotically controlled neurosurgical procedures. Its flagship product, the NeuroBlate System, utilizes focused laser energy to safely ablate pathological brain lesions, such as tumors, while minimizing damage to surrounding healthy tissue. Monteris Medical also provides various stereotactic anchoring devices and stabilization systems for enhanced precision during image-guided procedures. The company markets its products directly to neurosurgeons in the United States, aiming to improve surgical outcomes through advanced technology.

Materna Medical

Series B in 2022
Materna Medical, Inc. is a medical device company based in Mountain View, California, focused on developing innovative solutions to reduce maternal childbirth-related injuries during vaginal delivery. Established in 2010, the company addresses significant unmet needs in women's pelvic health, positioning itself within a $6 billion market. Materna Medical aims to transform the standard of care in obstetrics and gynecology by leveraging advanced technologies and a diverse team of engineers, scientists, and commercial leaders. The company’s mission is to empower women to safeguard their pelvic health through its novel medical devices.

Radiaction

Venture Round in 2022
Radiaction Medical, Ltd. is an innovative company based in Tel Aviv, Israel, that specializes in radiation protection solutions for interventional medical teams, particularly in high-exposure fields like interventional cardiology and electrophysiology. The company has developed Radiaction, a plug-and-play system that integrates with existing C-arm fluoroscopy systems to dynamically block over 90% of scatter radiation at its source, providing comprehensive head-to-toe protection for all personnel in the operating room. This approach marks a significant advancement over traditional protective measures such as lead aprons and shields. Radiaction has received both CE Marking and FDA clearance, facilitating its marketing in North America. Founded by Amir Belson, MD, and supported by lead investor InnovaHealth Partners, Radiaction Medical aims to address real-world challenges in radiation safety through engineering excellence and innovation.

Route 92

Series E in 2021
Route 92 Medical, established in 2015 and headquartered in San Mateo, California, specializes in the development of innovative medical devices for stroke treatment. Their flagship product is a stealthy catheter designed for rapid and efficient removal of blood clots during acute ischemic stroke, aiming to improve patient outcomes and enhance recovery. Additionally, the company offers a rapid aspiration thrombectomy system and an intra-cerebral implant delivery system, further expanding their capabilities in stroke care.

Radiaction

Series B in 2020
Radiaction Medical, Ltd. is an innovative company based in Tel Aviv, Israel, that specializes in radiation protection solutions for interventional medical teams, particularly in high-exposure fields like interventional cardiology and electrophysiology. The company has developed Radiaction, a plug-and-play system that integrates with existing C-arm fluoroscopy systems to dynamically block over 90% of scatter radiation at its source, providing comprehensive head-to-toe protection for all personnel in the operating room. This approach marks a significant advancement over traditional protective measures such as lead aprons and shields. Radiaction has received both CE Marking and FDA clearance, facilitating its marketing in North America. Founded by Amir Belson, MD, and supported by lead investor InnovaHealth Partners, Radiaction Medical aims to address real-world challenges in radiation safety through engineering excellence and innovation.

Koelis

Acquisition in 2019
Koelis is a developer of advanced medical imaging products specifically designed for urology. The company specializes in creating imaging systems that assist in guiding and mapping urological interventions within hospital settings. Its platform features organ-based tracking technology and multiparametric image fusion, which generates a digitized three-dimensional patient-specific prostate map. This innovative approach facilitates comprehensive prostate cancer management, enhancing diagnostic precision and improving cancer detection rates for urologists and radiologists.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.